Literature DB >> 3784543

A successful technique of in vivo isolated liver perfusion in pigs.

C J van de Velde, B J Kothuis, H W Barenbrug, N Jongejan, R D Runia, L M de Brauw, A Zwaveling.   

Abstract

A technique was developed to isolate the hepatic circulation from the general circulation using a double lumen intracaval shunt. Low flow normothermic perfusion of the liver was performed for 1 hr 25 min in pigs. All pigs survived the procedure. The isolated liver perfusion without chemotherapy (n = 11) was well tolerated as monitored by hepatic enzymes and histologic examination during and after the operation. Mild transient elevations of SGOT and LDH returned to normal values within 1 week. No significant pathological alterations were found in the liver biopsies. Twenty-two pigs were subjected to isolated liver perfusion with 20, 40, or 80 mg 5-FU/kg. Up to four times the conventional dose of the drug could safely be administered when a washout was performed. To evaluate the efficacy of the isolation a method for leakage detection was developed, using tracer quantities of 99mTc-labeled red blood cells. This method was sensitive and permitted continuous monitoring of leakage. Negligible leakage was found during 15 isolated liver perfusions. The described technique of isolated liver perfusion was a reliable and technically feasible method, and has been adapted for clinical use to evaluate its value in the treatment of hepatic metastases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3784543     DOI: 10.1016/0022-4804(86)90084-3

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

1.  Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs.

Authors:  M G van Ijken; E A de Bruijn; G de Boeck; T L ten Hagen; J R van der Sijp; A M Eggermont
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

2.  Isolated liver perfusion using percutaneous methods: an experimental study in the pig.

Authors:  J Harnek; W Cwikiel; L Bergqvist; B Persson; H Stridbeck
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

3.  Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver.

Authors:  Eleonora M de Leede; Mark C Burgmans; Christian H Martini; Fred G J Tijl; Arian R van Erkel; Jaap Vuyk; Ellen Kapiteijn; Cornelis Verhoef; Cornelis J H van de Velde; Alexander L Vahrmeijer
Journal:  J Vis Exp       Date:  2016-07-31       Impact factor: 1.355

4.  Endovascular Ion Exchange Chemofiltration Device Reduces Off-Target Doxorubicin Exposure in a Hepatic Intra-arterial Chemotherapy Model.

Authors:  Colin Yee; David McCoy; Jay Yu; Aaron Losey; Caroline Jordan; Terilyn Moore; Carol Stillson; Hee Jeung Oh; Bridget Kilbride; Shuvo Roy; Anand Patel; Mark W Wilson; Steven W Hetts
Journal:  Radiol Imaging Cancer       Date:  2019-09-27

5.  Isolated hepatic perfusion in the pig with TNF-alpha with and without melphalan.

Authors:  I H Borel Rinkes; M R de Vries; A M Jonker; T J Swaak; C E Hack; P T Nooyen; T Wiggers; A M Eggermont
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats.

Authors:  A Marinelli; C J van de Velde; P J Kuppen; H C Franken; J H Souverijn; A M Eggermont
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

7.  Evaluation of Delcath Systems' Generation 2 (GEN 2) melphalan hemofiltration system in a porcine model of percutaneous hepatic perfusion.

Authors:  Fred M Moeslein; Elizabeth G McAndrew; William M Appling; Nicole E Hryniewich; Kevin D Jarvis; Steven M Markos; Timothy P Sheets; Rajneesh P Uzgare; Daniel S Johnston
Journal:  Cardiovasc Intervent Radiol       Date:  2014-01-09       Impact factor: 2.740

Review 8.  Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies.

Authors:  Mark C Burgmans; Eleonora M de Leede; Christian H Martini; Ellen Kapiteijn; Alexander L Vahrmeijer; Arian R van Erkel
Journal:  Cardiovasc Intervent Radiol       Date:  2015-12-30       Impact factor: 2.740

9.  Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.

Authors:  A Marinelli; J H van Dierendonck; G M van Brakel; H Irth; P J Kuppen; U R Tjaden; C J van de Velde
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

10.  An evaluation of hepatic extraction and clearance of doxorubicin.

Authors:  D A August; N Verma; M A Vaertan; R Shah; D E Brenner
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.